\
&
Contact us
\
&
Contact us
This was 5 years ago
LocationOnline event
ProgrammesThis year's edition of the EU Industry Days will provide the participants the possibility to discuss industrial challenges and co-develop opportunities and policy responses in an inclusive dialogue with a wide range of partners.
It also helps to ensure that our policies at European, national, regional and local levels work together to enable European industry to deliver jobs, growth and innovation in Europe.
For more detailed information on this virtual event, the full programme and details on how to join, please click here
Source: EC info/events
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
